<DOC>
	<DOCNO>NCT01650155</DOCNO>
	<brief_summary>To investigate safety tolerability BI 1005273 healthy male volunteer follow intravenous ( i.v . ) infusion single rising dos subcutaneous ( s.c. ) injection . Secondary objective exploration pharmacokinetics early pharmacodynamics BI 1005273 .</brief_summary>
	<brief_title>Single Rising Dose Study With Intravenous Infusion Subcutaneous Injection BI 1005273 Healthy Male Volunteers .</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1 . Healthy male subject Exclusion criterion : 1 . Any deviation healthy condition</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>